Journal for ImmunoTherapy of Cancer (Nov 2021)

Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release

  • Nadine Aschmoneit,
  • Lennart Kühl,
  • Oliver Seifert,
  • Roland E Kontermann

DOI
https://doi.org/10.1136/jitc-2021-003616
Journal volume & issue
Vol. 9, no. 11

Abstract

Read online

No abstracts available.